Detailed information for compound 1042328

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 383.441 | Formula: C21H25N3O4
  • H donors: 2 H acceptors: 2 LogP: 3.28 Rotable bonds: 6
    Rule of 5 violations (Lipinski): 1
  • SMILES: O/N=C(/c1ccc(nc1)Oc1cccc2c1OC(C2)(C)C)\NCC1CCCO1
  • InChi: 1S/C21H25N3O4/c1-21(2)11-14-5-3-7-17(19(14)28-21)27-18-9-8-15(12-22-18)20(24-25)23-13-16-6-4-10-26-16/h3,5,7-9,12,16,25H,4,6,10-11,13H2,1-2H3,(H,23,24)
  • InChiKey: WKTOYMHMPZFNMH-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Trypanosoma cruzi apurinic/apyrimidinic endonuclease, putative 0.0019 0 0.5
Schistosoma mansoni metabotropic glutamate receptor 0.0069 0.607 0.6699
Trichomonas vaginalis ap endonuclease, putative 0.0019 0 0.5
Leishmania major apurinic/apyrimidinic endonuclease-redox protein 0.0019 0 0.5
Plasmodium vivax AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative 0.0019 0 0.5
Trypanosoma brucei apurinic/apyrimidinic endonuclease, putative 0.0019 0 0.5
Entamoeba histolytica exodeoxyribonuclease III, putative 0.0019 0 0.5
Brugia malayi Receptor family ligand binding region containing protein 0.0021 0.0261 0.034
Brugia malayi Metabotropic glutamate receptor precursor. 0.0082 0.7691 1
Loa Loa (eye worm) metabotropic GABA-B receptor subtype 2 0.0021 0.0261 0.0261
Echinococcus multilocularis metabotropic glutamate receptor 2 0.0069 0.607 0.607
Trypanosoma cruzi apurinic/apyrimidinic endonuclease 0.0019 0 0.5
Trichomonas vaginalis ap endonuclease, putative 0.0019 0 0.5
Loa Loa (eye worm) glutamate receptor 0.0082 0.7691 0.7691
Giardia lamblia Endonuclease/Exonuclease/phosphatase 0.0019 0 0.5
Mycobacterium tuberculosis Probable exodeoxyribonuclease III protein XthA (exonuclease III) (EXO III) (AP endonuclease VI) 0.0019 0 0.5
Brugia malayi metabotropic glutamate receptor type 2 0.004 0.257 0.3341
Brugia malayi metabotropic glutamate receptor subtype 5a (mGluR5a), putative 0.0074 0.6752 0.8779
Loa Loa (eye worm) glutamate receptor 0.0032 0.1631 0.1631
Loa Loa (eye worm) hypothetical protein 0.0101 1 1
Schistosoma mansoni metabotropic glutamate receptor 2 3 (mglur group 2) 0.0093 0.9061 1
Toxoplasma gondii exonuclease III APE 0.0019 0 0.5
Wolbachia endosymbiont of Brugia malayi exonuclease III 0.0019 0 0.5
Echinococcus multilocularis metabotropic glutamate receptor 5 0.0101 1 1
Treponema pallidum exodeoxyribonuclease (exoA) 0.0019 0 0.5
Schistosoma mansoni metabotropic glutamate receptor 0.004 0.257 0.2836
Plasmodium falciparum AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative 0.0019 0 0.5
Loa Loa (eye worm) receptor family ligand binding region containing protein 0.0021 0.0261 0.0261
Mycobacterium ulcerans exodeoxyribonuclease III protein XthA 0.0019 0 0.5
Echinococcus granulosus metabotropic glutamate receptor 2 0.0069 0.607 0.607
Loa Loa (eye worm) hypothetical protein 0.0021 0.0261 0.0261

Activities

Activity type Activity value Assay description Source Reference
Inhibition (functional) = 8 % DNDI: Inhibition of Human African Trypanosomiasis, SBRI 427, in vitro at 2 ug.mL-1 ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.